Glaucoma Market 2027 By Disease Indication, Drug class, Surgery, End Users and Geography | The Insight Partners

Glaucoma Market to 2027 - Global Analysis and Forecasts by Disease Indication (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma and Other); Drug class (Prostaglandin Analogs (PGAs), Alpha Agonist, Beta Blockers, Cholinergic Drugs, Carbonic Anhydrase Inhibitors and Others); Surgery (Laser Iridotomy, Laser Trabeculoplasty, Aqueous Shunt Surgery and Peripheral Iridectomy); End Users (Hospitals, Clinics, Home Users) and Geography

Report Code: TIPRE00006204 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

The medical condition where eye's optic nerve is damaged is termed as glaucoma. The most common glaucoma condition is inherited and often may not show later in life. People with diabetes are at risk of developing this condition. If not treated on time it may lead to visual loss.

MARKET DYNAMICS

The Glaucoma market is anticipated to grow in the forecast, owing to rising geriatric population, growing prevalence of diabetes and newly developed technologies to treat glaucoma. In addition, the growing adoption of laser surgery to treat glaucoma is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Glaucoma market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Glaucoma market with detailed market segmentation by disease indication, surgery, drug class, end users and geography. The global Glaucoma market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Glaucoma market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Glaucoma market is segmented on the basis of disease indication, surgery, drug class, end users. Based on disease indication, the market is segmented as, closed angle glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. Based on drug class, the market is segmented in to prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors and others. Based on surgery the market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis of end user, the glaucoma market is categorized as hospitals, clinics, home users.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Glaucoma market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glaucoma market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Glaucoma market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glaucoma market in these regions.

MARKET PLAYERS

The reports cover key developments in the Glaucoma market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Glaucoma market are anticipated to lucrative growth opportunities in the future with the rising demand for Glaucoma market in the global market. Below mentioned is the list of few companies engaged in the Glaucoma market.

The report also includes the profiles of key Glaucoma market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Novartis AG
- Pfizer Inc.
- Allergan
- Merck & Co
Ocular Therapeutix Inc
- pSivida Corp
- Icon Bioscience Inc
- Amorphex Therapeutics LLC.
- Ellex
- Quantel

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Glaucoma Market - By Disease Indication
1.3.2 Glaucoma Market - By Drug class
1.3.3 Glaucoma Market - By Surgery
1.3.4 Glaucoma Market - By End Users
1.3.5 Glaucoma Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GLAUCOMA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GLAUCOMA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GLAUCOMA MARKET - GLOBAL MARKET ANALYSIS
6.1. GLAUCOMA - GLOBAL MARKET OVERVIEW
6.2. GLAUCOMA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GLAUCOMA MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
7.1. OVERVIEW
7.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
7.3. CLOSED ANGLE GLAUCOMA (CAG)
7.3.1. Overview
7.3.2. Closed Angle Glaucoma (CAG) Market Forecast and Analysis
7.4. OPEN ANGLE GLAUCOMA (OAG)
7.4.1. Overview
7.4.2. Open Angle Glaucoma (OAG) Market Forecast and Analysis
7.5. SECONDARY GLAUCOMA
7.5.1. Overview
7.5.2. Secondary Glaucoma Market Forecast and Analysis
7.6. CONGENITAL GLAUCOMA AND OTHER
7.6.1. Overview
7.6.2. Congenital Glaucoma and Other Market Forecast and Analysis
8. GLAUCOMA MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. PROSTAGLANDIN ANALOGS (PGAS)
8.3.1. Overview
8.3.2. Prostaglandin Analogs (PGAs) Market Forecast and Analysis
8.4. ALPHA AGONIST
8.4.1. Overview
8.4.2. Alpha Agonist Market Forecast and Analysis
8.5. BETA BLOCKERS
8.5.1. Overview
8.5.2. Beta Blockers Market Forecast and Analysis
8.6. CHOLINERGIC DRUGS
8.6.1. Overview
8.6.2. Cholinergic Drugs Market Forecast and Analysis
8.7. CARBONIC ANHYDRASE INHIBITORS
8.7.1. Overview
8.7.2. Carbonic Anhydrase Inhibitors Market Forecast and Analysis
8.8. AND OTHERS
8.8.1. Overview
8.8.2. and Others Market Forecast and Analysis
9. GLAUCOMA MARKET - REVENUE AND FORECASTS TO 2027 - SURGERY
9.1. OVERVIEW
9.2. SURGERY MARKET FORECASTS AND ANALYSIS
9.3. LASER IRIDOTOMY
9.3.1. Overview
9.3.2. Laser Iridotomy Market Forecast and Analysis
9.4. LASER TRABECULOPLASTY
9.4.1. Overview
9.4.2. Laser Trabeculoplasty Market Forecast and Analysis
9.5. AQUEOUS SHUNT SURGERY AND PERIPHERAL IRIDECTOMY
9.5.1. Overview
9.5.2. Aqueous Shunt Surgery and Peripheral Iridectomy Market Forecast and Analysis
10. GLAUCOMA MARKET - REVENUE AND FORECASTS TO 2027 - END USERS
10.1. OVERVIEW
10.2. END USERS MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. Clinics Market Forecast and Analysis
10.5. HOME USERS
10.5.1. Overview
10.5.2. Home Users Market Forecast and Analysis
11. GLAUCOMA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Glaucoma Market Overview
11.1.2 North America Glaucoma Market Forecasts and Analysis
11.1.3 North America Glaucoma Market Forecasts and Analysis - By Disease Indication
11.1.4 North America Glaucoma Market Forecasts and Analysis - By Drug class
11.1.5 North America Glaucoma Market Forecasts and Analysis - By Surgery
11.1.6 North America Glaucoma Market Forecasts and Analysis - By End Users
11.1.7 North America Glaucoma Market Forecasts and Analysis - By Countries
11.1.7.1 United States Glaucoma Market
11.1.7.1.1 United States Glaucoma Market by Disease Indication
11.1.7.1.2 United States Glaucoma Market by Drug class
11.1.7.1.3 United States Glaucoma Market by Surgery
11.1.7.1.4 United States Glaucoma Market by End Users
11.1.7.2 Canada Glaucoma Market
11.1.7.2.1 Canada Glaucoma Market by Disease Indication
11.1.7.2.2 Canada Glaucoma Market by Drug class
11.1.7.2.3 Canada Glaucoma Market by Surgery
11.1.7.2.4 Canada Glaucoma Market by End Users
11.1.7.3 Mexico Glaucoma Market
11.1.7.3.1 Mexico Glaucoma Market by Disease Indication
11.1.7.3.2 Mexico Glaucoma Market by Drug class
11.1.7.3.3 Mexico Glaucoma Market by Surgery
11.1.7.3.4 Mexico Glaucoma Market by End Users
11.2. EUROPE
11.2.1 Europe Glaucoma Market Overview
11.2.2 Europe Glaucoma Market Forecasts and Analysis
11.2.3 Europe Glaucoma Market Forecasts and Analysis - By Disease Indication
11.2.4 Europe Glaucoma Market Forecasts and Analysis - By Drug class
11.2.5 Europe Glaucoma Market Forecasts and Analysis - By Surgery
11.2.6 Europe Glaucoma Market Forecasts and Analysis - By End Users
11.2.7 Europe Glaucoma Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Glaucoma Market
11.2.7.1.1 Germany Glaucoma Market by Disease Indication
11.2.7.1.2 Germany Glaucoma Market by Drug class
11.2.7.1.3 Germany Glaucoma Market by Surgery
11.2.7.1.4 Germany Glaucoma Market by End Users
11.2.7.2 France Glaucoma Market
11.2.7.2.1 France Glaucoma Market by Disease Indication
11.2.7.2.2 France Glaucoma Market by Drug class
11.2.7.2.3 France Glaucoma Market by Surgery
11.2.7.2.4 France Glaucoma Market by End Users
11.2.7.3 Italy Glaucoma Market
11.2.7.3.1 Italy Glaucoma Market by Disease Indication
11.2.7.3.2 Italy Glaucoma Market by Drug class
11.2.7.3.3 Italy Glaucoma Market by Surgery
11.2.7.3.4 Italy Glaucoma Market by End Users
11.2.7.4 Spain Glaucoma Market
11.2.7.4.1 Spain Glaucoma Market by Disease Indication
11.2.7.4.2 Spain Glaucoma Market by Drug class
11.2.7.4.3 Spain Glaucoma Market by Surgery
11.2.7.4.4 Spain Glaucoma Market by End Users
11.2.7.5 United Kingdom Glaucoma Market
11.2.7.5.1 United Kingdom Glaucoma Market by Disease Indication
11.2.7.5.2 United Kingdom Glaucoma Market by Drug class
11.2.7.5.3 United Kingdom Glaucoma Market by Surgery
11.2.7.5.4 United Kingdom Glaucoma Market by End Users
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Glaucoma Market Overview
11.3.2 Asia-Pacific Glaucoma Market Forecasts and Analysis
11.3.3 Asia-Pacific Glaucoma Market Forecasts and Analysis - By Disease Indication
11.3.4 Asia-Pacific Glaucoma Market Forecasts and Analysis - By Drug class
11.3.5 Asia-Pacific Glaucoma Market Forecasts and Analysis - By Surgery
11.3.6 Asia-Pacific Glaucoma Market Forecasts and Analysis - By End Users
11.3.7 Asia-Pacific Glaucoma Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Glaucoma Market
11.3.7.1.1 Australia Glaucoma Market by Disease Indication
11.3.7.1.2 Australia Glaucoma Market by Drug class
11.3.7.1.3 Australia Glaucoma Market by Surgery
11.3.7.1.4 Australia Glaucoma Market by End Users
11.3.7.2 China Glaucoma Market
11.3.7.2.1 China Glaucoma Market by Disease Indication
11.3.7.2.2 China Glaucoma Market by Drug class
11.3.7.2.3 China Glaucoma Market by Surgery
11.3.7.2.4 China Glaucoma Market by End Users
11.3.7.3 India Glaucoma Market
11.3.7.3.1 India Glaucoma Market by Disease Indication
11.3.7.3.2 India Glaucoma Market by Drug class
11.3.7.3.3 India Glaucoma Market by Surgery
11.3.7.3.4 India Glaucoma Market by End Users
11.3.7.4 Japan Glaucoma Market
11.3.7.4.1 Japan Glaucoma Market by Disease Indication
11.3.7.4.2 Japan Glaucoma Market by Drug class
11.3.7.4.3 Japan Glaucoma Market by Surgery
11.3.7.4.4 Japan Glaucoma Market by End Users
11.3.7.5 South Korea Glaucoma Market
11.3.7.5.1 South Korea Glaucoma Market by Disease Indication
11.3.7.5.2 South Korea Glaucoma Market by Drug class
11.3.7.5.3 South Korea Glaucoma Market by Surgery
11.3.7.5.4 South Korea Glaucoma Market by End Users
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Glaucoma Market Overview
11.4.2 Middle East and Africa Glaucoma Market Forecasts and Analysis
11.4.3 Middle East and Africa Glaucoma Market Forecasts and Analysis - By Disease Indication
11.4.4 Middle East and Africa Glaucoma Market Forecasts and Analysis - By Drug class
11.4.5 Middle East and Africa Glaucoma Market Forecasts and Analysis - By Surgery
11.4.6 Middle East and Africa Glaucoma Market Forecasts and Analysis - By End Users
11.4.7 Middle East and Africa Glaucoma Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Glaucoma Market
11.4.7.1.1 South Africa Glaucoma Market by Disease Indication
11.4.7.1.2 South Africa Glaucoma Market by Drug class
11.4.7.1.3 South Africa Glaucoma Market by Surgery
11.4.7.1.4 South Africa Glaucoma Market by End Users
11.4.7.2 Saudi Arabia Glaucoma Market
11.4.7.2.1 Saudi Arabia Glaucoma Market by Disease Indication
11.4.7.2.2 Saudi Arabia Glaucoma Market by Drug class
11.4.7.2.3 Saudi Arabia Glaucoma Market by Surgery
11.4.7.2.4 Saudi Arabia Glaucoma Market by End Users
11.4.7.3 U.A.E Glaucoma Market
11.4.7.3.1 U.A.E Glaucoma Market by Disease Indication
11.4.7.3.2 U.A.E Glaucoma Market by Drug class
11.4.7.3.3 U.A.E Glaucoma Market by Surgery
11.4.7.3.4 U.A.E Glaucoma Market by End Users
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Glaucoma Market Overview
11.5.2 South and Central America Glaucoma Market Forecasts and Analysis
11.5.3 South and Central America Glaucoma Market Forecasts and Analysis - By Disease Indication
11.5.4 South and Central America Glaucoma Market Forecasts and Analysis - By Drug class
11.5.5 South and Central America Glaucoma Market Forecasts and Analysis - By Surgery
11.5.6 South and Central America Glaucoma Market Forecasts and Analysis - By End Users
11.5.7 South and Central America Glaucoma Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Glaucoma Market
11.5.7.1.1 Brazil Glaucoma Market by Disease Indication
11.5.7.1.2 Brazil Glaucoma Market by Drug class
11.5.7.1.3 Brazil Glaucoma Market by Surgery
11.5.7.1.4 Brazil Glaucoma Market by End Users
11.5.7.2 Argentina Glaucoma Market
11.5.7.2.1 Argentina Glaucoma Market by Disease Indication
11.5.7.2.2 Argentina Glaucoma Market by Drug class
11.5.7.2.3 Argentina Glaucoma Market by Surgery
11.5.7.2.4 Argentina Glaucoma Market by End Users
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. GLAUCOMA MARKET, KEY COMPANY PROFILES
13.1. NOVARTIS AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ALLERGAN
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MERCK AND CO.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. OCULAR THERAPEUTIX INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PSIVIDA CORP
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ICON BIOSCIENCE INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. AMORPHEX THERAPEUTICS LLC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ELLEX
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. QUANTEL
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. LUMENIS
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
13.12. LIGHTMED
13.12.1. Key Facts
13.12.2. Business Description
13.12.3. Products and Services
13.12.4. Financial Overview
13.12.5. SWOT Analysis
13.12.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Pfizer Inc.
3. Allergan
4. Merck & Co
5. Ocular Therapeutix Inc
6. pSivida Corp
7. Icon Bioscience Inc
8. Amorphex Therapeutics LLC.
9. Ellex
10. Quantel